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It has been demonstrated that patients with poliomyelitis, as a  rule, have 
neutralizing antibody for the infecting strain of virus early after onset of first 
symptoms before the appearance of paralysis, and that this antibody increases 
in  titer  during  convalescence  (1,  2).  For  a  better  understanding  of human 
immunity to poliomyelitis and of the part immune individuals may play in the 
dissemination of the virus in nature, it is necessary to know for how long and 
at what level homotypic neutralizing antibodies persist. The quantitative esti- 
mation of antibody was regarded as important because it is conceivable that 
the response to reinfection may be determined not so much by mere presence 
or absence of antibody as by the amount of antibody that is present. 
The  purpose  of  the  present  investigation  was  to  determine  whether  the 
homotypie neutralizing antibody,  after reaching peak  levels  several months 
after the onset of clinically recognized poliomyelitis, persisted for many years, 
rapidly diminished in concentration, or even completely disappeared. A num- 
ber of patients from whose alimentary tract poliomyelitis virus was recovered 
during  the  acute phase  of their  illness  and  whose sera  had  been  tested for 
neutralizing antibody against the recovered strain up to 3 months after onset 
(1) were available for study 3 years later. Since the strains of virus as well as 
the 3  month convalescent sera had been preserved, it was possible in simul- 
taneous quantitative  tests  on the sera  obtained 3  months and 3  years after 
onset, to determine what had happened to the antibody against the infecting 
strain  of  virus. All  the  strains  of poliomyelitis virus  recovered from  these 
patients  were  classified  immunologically and  found  to  be Type  1,  the  type 
most frequently encountered in epidemics of the disease (3). As a check on the 
extent to which these patients may have been exposed to poliomyelitis virus 
during  the 3  year interval,  their sera  were also  tested for neutralizing anti- 
bodies against Type 2  (Lansing) poliomyelitis virus. 
Materials and Methods 
Pat/eats Stud/cal.--The 7 patients, part of a group previously studied in this laboratory, 
were described in a previous communication (1). 6 had the paralytic disease, and one (Hof.) 
* Aided by a grant from The National Foundation for Infantile Paralysis, Inc. 
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exhibited the syndrome of aseptic meningitis which was diagnosed as non-paralytic polio- 
myelitis. The patients resided in or near Cincinnati or Akron, and had their illness in 1947 
during a  moderate outbreak of poliomyelitis in the community. 
Serum  Spezimcns.--The specimens collected in 1947 were stored in the frozen  state in a 
chest containing solid CO2. The 3 year specimens,  ~ which were obtained between the end of 
May and early June of 1950 (except that of Ten. J. which was obtained July 10,  1950), were 
similarly stored in the frozen state until they were tested in 1951. 
Strains  of Virus.--The strains of virus recovered from these patients in  1947  were also 
stored in the frozen state in a chest containing solid C(h. In 5 instances titrated lots of virus, 
which were used in the previous tests for antibody (1), were available for the present study. 
TABLE  I 
Persistence of Titer in Stored Poliomyelitis  Viruses  Used in Quantitative Neutralization  Tests 
20 per cent centrifuged suspensions in saline stored in rubber-capped vaccine vials in chest 
containing solid C02. 
Strain of virus 
Obe. 
Ric. 
Ten. J. 
Hof. 
Fin. 
Ris. 
Fro. 
Passage No.  Date prepared 
Intracerebral titer* in monkeys 
Titer of single  ti- 
trations in 1951 
3-  5-48 
12- 8-47 
2-20-48 
2-26-48 
3-  8-48 
10-18-48 
11-17--47 
Cumulative  titer 
in 1948 
3.6 (4.0+?):~ 
3.6 (3.5)$ 
4.1  (5.0+?)~ 
4.3 
2.9 
Not tested (3.8) § 
....  (3.3)§ 
4.2 
4.3; 
5.3 
4.2; 
3.3 
4.5 
4.2 
4.5 
3.8 
All dilutions prepared in saline and 0.5 ml. injected into the thalamic region of each of 4 
rhesus monkeys. 
In 1948, all dilutions were incubated at room temperature (~25°C.) for 1 hour and over- 
night at about 4°C. 
In 1951, only the dilution used in the neutralization test (usually 10  4 ) was similarly incu- 
bated. The higher dilutions were prepared from the incubated dilution just before inoculation. 
* Reciprocal of log of PDs0 (50 per cent poliomyelitis dose); thus 1 X  10  -t'e is recorded as 
3.6. 
$ Titers in parentheses represent those obtained in single titrations in 1948  on material 
from  same  vial used  in  1951. 
§ Titers in parentheses represent those obtained in 1948 with passage 2 material. 
Each strain of virus was retitrated at the time it was used in the quantitative neutralization 
test, and the data shown in Table I  indicate that full potency was maintained during the 3 
year  period  of  storage. 
Tests for Neutralizing  Antibody  against Patient's  Own Virus.--Although the titer of anti- 
body in the 3-month convalescent sera had been determined previously (1), it was deemed 
necessary to retitrate them simultaneously with the 3-year sera for a valid comparison of the 
level of antibody. The unexpectedly higher titers obtained in 1951 with some of the 3-month 
sera (Table II) indicate how important it is that such quantitative comparisons be made in 
1 We are indebted to Dr. Margaret Baker of The Children's Hospital of Akron for obtaining 
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a simultaneous test. Fourfold dilutions of the sera were prepared in saline (0.9 per cent solu- 
tion of NaCI) and mixed with an equal volume of a  predetermined dilution of the patient's 
own virus, also prepared in saline. For control an equal volume of saline was added to the virus. 
The mixtures were left at room temperature (24--27°C.)  for 1 hour and in the refrigerator at 
about 4°C.  for 18 hours.  Immediately prior to inoculation, tenfold dilutions in saline were 
prepared from the saline control tube to determine the number of PD~d of virus used in the 
test. 0.5 ml. of each serum-virus mixture or virus dilution was injected intracerebrally into 
each of 4 rhesus monkeys. The serum dilutions to be tested were selected on the basis of the 
titers exhibited by the 3 month sera in 1948.  An attempt was made to have 20 to 60 PD60 
of virus in the 0.5 ml. inoculum, and the virus dilution was selected on the basis of the cumu- 
lative titer of the virus in 1948. The monkeys were observed for paralysis, and all those which 
survived for 28 days without paralysis were sacrificed and the nervous system examined for 
histological evidence of non-paralytic poliomyelitis.  Both  paralytic  and  non-paralytic in- 
fections were counted in the calculation of the PDs0 titer of the virus and of the 50 per cent 
protective dilution of the serum; both calculations were made by the method of Reed and 
Muench. When the titration of the serum yielded no end-point, the minimum protective titer 
was estimated on the assumption that the next fourfold dilution of serum would have failed 
to protect all the animals. 
When it was necessary to determine the neutralizing capacity of undiluted serum, it was 
mixed with equal volumes of tenfold dilutions of virus, and for control all the virus dilutions 
were mixed with an equal volume of saline. The subsequent incubation and inoculation of 
monkeys were carried out as above. 
Tests for Type 2 Neutralizing Antibody in Mice.--A pool of mouse-passaged, Lansing virus 
with a cumulative intracerebral LDs0 titer of 10  -~-a was used. The procedure for the qualita- 
tive and quantitative tests was described previously (4), and the neutralization indices were 
calculated from the LD~0 titers obtained after an observation period of 35 days. 
RESULTS 
The  results  of  the  quantitative  tests  for  neutralizing  antibody  against  the 
patients'  own viruses are summarized  in Table  II,  and  the detailed protocols 
are shown in Tables V, VI, and VII of the Appendix. 6 of the 7  patients studied 
exhibited surprisingly high titers of antibody  against  the strain of virus with 
which they were infected 3  years ago.  The  titers were  in fact so unexpectedly 
high that  an end-point was reached in only 1  of the 12 sera tested.  Inspection 
of  the  data  in Table  II  reveals  that  these high titers  are  not  due  to  the  use 
of  very  small  doses  of  virus,  for  the  simultaneous  titrations  of  the  viruses 
indicated the presence of  100 to  1000  PDs0. 
The higher titers obtained in the 1951 tests on the 3 month sera present a puzzling problem 
in at least 3 of the patients for whom adequate end-points were obtained in the 1948 titrations 
(1). In the case of patient Obe., whose 3 month serum yielded a  titer of 1:64 in 1948  and 
1 : 776+? in 1951, the same ampoule of virus was used in both titrations but the final dilution 
of virus in the test was  1:50 in 1948 and 1:100 in 1951.  In the case of patient Ris., whose 
3 month serum yielded a titer of 1:26 in 1948 and 1:256+? in 1951, another lot of virus, rep- 
resenting the next passage, was used in 1951, but the number of PD~0 of virus in the test was 
PD6o means 50 per cent poliomyelitis dose because the calculation takes into account the 
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320; i.e., in the same range as that in 1948. In the case of patient Fro. the difference between 
the fiter of 1 : 6 in 1948 and 1: 256+ in 1951 is most marked; here an earlier passage virus was 
used in greater dilution  in 1951, but the final concentration of virus in the test was still 160 
PD60. While one must consider the possibility  that the number of animals used in the tests 
may he too small to yield reproducible  results, the 10- to 40-fold differences in titer are very 
great and the number of monkeys actually used, i.e. 4 per dilution,  is not much smaller than 
the usual 5 or 6 mice per dilution used for other viruses in tests which have been found to be 
fairly reproducible.  Although  the 3 month sera had been submitted to several freezings and 
thawing,  s, which might conceivably increase the number of effective antibody groupings, the 
3 year sera, which also yielded high fiters, were frozen and thawed only once. Since nothing is 
known of the quantitative relatiouships  between Type 1 poliomyelitis virus and antibody and 
the numbers of virus particles per infective dose, it is not possible further to analyze these 
differences. 
Since  the  3  year sera were found  to have such  unexpectedly  high  titers  of 
antibody,  it did not seem worthwhile  to expend the large number of monkeys 
that  would  have been required  for the  determination  of exact end-points.  In 
at least one patient,  Fin,  the 3  year titer appears to be lower than  that at 3 
months. Thus, while the absence of end-points makes it impossible to say that 
the level of antibody at 3 years has dropped or risen as compared to that at 3 
months,  it  is,  nevertheless,  clear  that  the  amount  of homotypic  neutralizing 
antibody possessed by these 6 paralytic patients is of a  very high order.  It is 
also noteworthy  that  the  2 children,  who were only 6  months old at the  time 
of  their  illness,  had  antibody  of  the  same  high  order  of  magnitude  as  the 
older ones. 
The  data  obtained  on  patient  Hof.  need  special  consideration  (see Tables 
II, III, and VII). The original studies (1) revealed a negligible or questionable 
response of neutralizing  antibody  to the virus derived  from the patient's  ali- 
mentary  tract  during  the  acute  phase  of  the  non-paralytic  illness.  In  the 
1951 test, the 3 month serum failed to neutralize 32 PD60 of virus, although in 
1948  this  serum yielded  a  neutralization  index  of 63.  The 3  year serum  also 
failed to neutralize  32  PD~0 of virus.  The possibility was considered  that  the 
Hof. strain  of virus might contain  an exceptionally  large number  of particles 
per infective dose and might thus be particularly difficult to neutralize. Accord- 
lngly,  the 3  year convalescent  serum of another patient  (Ric.)  from the  same 
outbreak  was  tested  against  the  Hof.  virus  (Table  III),  and  the  virus  was 
neutralized.  As  a  further  check  on  the  presence  of neutralizing  antibody  in 
the  various  serum  specimens  of  patient  Hof.  they  were  tested  against  the 
strain  derived  from patient  Ric.  (Table  III). Again,  only  a  questionable  or 
negligible amount of neutralization  was evident with the 34 day and 250 day 
specimens  and  essentially  none  in  the  3  year specimen.  At  the  present  time 
one cannot choose among the following explanations:  (a) the illness was caused 
by  the recovered virus, but the patient produced  a  negligible or questionable 
amount  of neutralizing  antibody;  (b)  the recovered virus was merely passing 
through  the alimentary tract and was not responsible for the infection,  which, ]OHAN  WINSSER AND  ALBERT  B,  SABIN  481 
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however,  was  caused  by  another  immunologic  type  of poliomyelitis virus; 
(c)  the  syndrome  of  aseptic  meningitis  exhibited  by  this  patient  was  not 
caused  by poliomyelitis virus.  The possibility  of a  mislabeled  or  mixed-up 
specimen seems remote. The patient had neither neutralizing nor complement- 
fixing antibodies  for Type 2  poliomyelitis virus  (1,  4)  (see  also  Table IV). 
Complement-fixation  tests  with  Type  1  and  Type 3  poliomyelitis antigens 
TABLE III 
Data on Patient Hof. with Questionable or Negligible Antibody Response 
(a) Neutralizability of Hof. virus by convalescent serum from another Type I  patient  (Pie.) 
from same outbreak. 
(b) Neutralizability of Ric. virus by Hof. convalescent  sera. 
Virus  Ytre  f 
in test  s~ 
Hof. 
Ric. 
1951 
Poliomyelitis in monkeys at indicated  final dilutions of virus 
Serum 
10-2  10-4 
None 
Hof.~ 34  days 
Hof.--250  " 
None 
Ric.--3 yrs. 
None 
Ric.--3 yrs. 
Hof.--  34 days 
Hof.--250  " 
Hof.--3 yrs. 
6,  7,  13 
6,  10,  NP 
0,  0,  0, 
6,  7, 
O,  O, 
6,  7, 
®,  9, 
5,  7, 
10s 
6,  6,  7 
6,  12,  12 
20,  O,  0 
8,  9,  9,  12 
oo,  o,  ®,  @ 
9  5,  7,  9,  12 
7,  9,  18,  NP 
0,  0 
8,  0  9,  12,  0,  0 
9,  13  7,  9,  0,  0 
7,  8  9,  9,  10,  0 
9,  lf,  0 
0,  0,  0 
0,  0,  0 
6,  0,  O,  ® 
6,  7,  11,  0 
7,  10,  13,  25 
PDso 
10-s 
10- 
--  L2+? 
--  L5 
--  2,7 
--  3.8 
1.5--? 
0,  0,  0,  9  4.4 
--  1.5--? 
--  2.8+? 
--  '  3.0+? 
__  I 3.3+? 
Neutra- 
lization 
index  of 
,,ill. 
diluted 
sernn~ 
5+? 
32+? 
2OO+? 
800+? 
40--? 
25--? 
13--? 
Legends for Tables III, V, VI and VII:- 
Figures refer to day after inoculation  paralysis first noted  in individual monkeys. 
0  ffi no histologic evidence of poliomyelitis in monkeys sacrificed about  4 weeks after inoculation. 
Encircled figure ®  indicates day of death of monkey exhibiting no histologic evidence of poliomyelitis. 
NP  ffi non-paralytic  poliomyelitis  based  on  histologic changes in sacrificed monkey. 
* The data recorded  here are  from a  previous report  (1). 
derived from tissue cultures were unsatisfactory with the 3  day and  14 day 
specimens,  and yielded titers  of  1:2  with Type  1 at  both 3  months  and  8 
months and of 1:8 with Type 3 at both 3 months and 8 months. The 14 day 
serum in a final dilution of 1:16 failed to neutralize in tissue culture 100 tissue 
culture doses of Type 1 virus but did neutralize 100  tissue  culture doses of 
Type 3 virus? This merely indicates that this patient can produce neutralizing 
antibody and suggests, but does not prove, that the patient's 1947 illness may 
s We are indebted to Dr. John Enders and Dr. A. Svedmyr of The Children's Hospital of 
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have been  caused  by another  type of poliomyelitis virus:  The  occurrence of 
what may be interpreted as minimal amounts of Type 1 neutralizing antibody 
in the  1 month, 3  month,  and 8 month sera,  but not in the acute phase or 3 
year sera, could represent a transitory response to infection with a heterologous 
immunologic  type  of  poliomyelitis  virus  (4). 
Tests for  Type  2  Poliomyelitis  Neutralizing  Antibody.--In  the  group  of  7 
patients studied, there were 5 without evidence of previous infection with Type 
2  poliomyelitis  virus,  although  4  of these  5  showed evidence  of a  transitory 
response during the course of their  infection  with  Type  1 poliomyelitis  virus 
TABLE IV 
Type 2 Poliomyelitis Neutralizing Antibody as an Index of Exposure to Poliorayditis Virus of 
Patients  Studied  over Period  of 3  Years 
Type 1 poliomyelitis virus recovered from all these patients during acute phase of illness. 
Patient  Age at  onset 
yrs. 
Obe.  13 
Fin.  8 
Fro.  6/12 
Hof.  4 
Ris.  1 6/12 
Ric.  6/12 
Ten. J.  7 
Neutralization  index  of  undiluted  sera  obtained  at indicated 
periods after onset vs.  Lansing  virus in mice 
2 wks.  4 wks. 
1,000  250 
32  50 
250 
16--  10-- 
63  32 
20--  16-- 
20  10 
3  mos. 
5- 
6-- 
32 
5-- 
4-- 
160+  (1:200)* 
800  (1:4)* 
Onset 
5-- 
13-- 
13-- 
5-- 
25 
3 yrs. 
8 D 
8-- 
6-- 
8-- 
50?; 25 
(1:200)* 
50 (1:2)* 
Some of the data recorded in this table appeared  in prevtous reports  (1, 4). 
* The figures in parenthesis  represent  the 50 per cent protective  dilution  of serum  vs. 
100 PDs0 of Lansing virus. 
(4).  In this  group of 5,  none developed  a  significant amount  of antibody for 
Type 2 poliomyelitis virus during the 3 year interval.  This suggests that these 
patients  did not live in an environment in which they were often exposed  to 
poliomyelitis virus,  and  the  exceptionally high  titers  for Type  1 virus  in  the 
3 year sera are,  therefore,  more likely due  to persistence  of antibody than  to 
repeated  antigenic stimulation  resulting  from frequent  reinfection. 
The  remaining  2  patients  (Ric.  and  Ten.  J)  of  this  group  had  acquired 
4 Further tests for neutralizing antibody in tissue culture  by Drs. Svedmyr and Enders, 
indicated  that the titer of Type 3 (Leon) antibody was already very high (>  1:288) 3 days 
after onset of first symptoms, and no higher  at 3 months, when it was 1:128. One  cannot 
conclude from this that the current illness was caused by Type 3 virus, although  the possi- 
bility of such an infection with  unusually early  development of antibody  in very high  titer 
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Type 2 neutralizing antibody, presumably owing to inapparent infection with 
Type 2 virus between  1 month and 3 months after their paralytic illness due 
to Type 1 virus.  In a simultaneous  test for Type 2 neutralizing antibody on 
the 3 month and 3 year sera of patient Ric., the 50 per cent protective dilu- 
tion of both was found to be 1:200. Simultaneous  tests on the sera of patient 
Ten. J. indicated that this individual developed a low level of antibody initially 
which dropped  somewhat in 3 years, but did not disappear. 
DISCUSSION 
The present investigation revealed that 3 years after an attack of paralytic 
poliomyelitis  due to Type 1 virus,  human beings possess unexpectedly high 
levels of neutralizing antibody for the strain of virus recovered from their own 
alimentary tract. One important question  relative to these results is whether 
they mean that neutralizing antibody, once formed,  persists  in high titer for 
many years, or whether the level of antibody, after reaching  a peak shortly 
after infection,  drops  fairly rapidly in the ensuing months, the seeming per- 
sistence  being  due to  antigenic  boosters  resulting  from frequent reinfection 
whenever the level falls to a certain critical minimum (5). The latter alternative 
of necessity assumes that the individual lives in an environment in which the 
opportunities for infection with poliomyelitis virus are frequent and numerous. 
This is hardly the case for the children living in the region of Akron or Cin- 
cinnati, where 60 per cent are still without Lansing (Type 2) neutralizing anti- 
body at 5 years of age (6). The tests for Lansing antibody on the present group 
showed that the 5 patients, who had no evidence of previous  infection  with 
Type 2  virus,  had  not  become  infected  with  this  virus  during the  3  year 
interval. 
Frequent inapparent or  unrecognized  reinfection  does not appear  to be  a 
plausible explanation for the high levels of antibody encountered in the present 
group of patients 3 years after the disease. That neutralizing  antibody against 
the 3 known types of poliomyelitis virus most likely persists for many more than 
3 years after a single apparent or inapparent infection is strongly indicated by 
the recent report of Paul, Riordan, and Melnick (7) on the limited occurrence 
of these antibodies  in individuals  of specific age groups among certain North 
Alaskan Eskimos. 
In a quantitative study of gamma globulin derived from the pooled plasma 
of thousands of adult Americans, Bodian (8) found that the 50 per cent pro- 
tective titer against  100  PD~0 of Type 1 virus  (Brunhilde  strain)  was only 
1:100.  Since the gamma globulin preparation was said to represent  a 23-fold 
concentration of that in the plasma, the mean titer of antibody in the adult 
plasma would be only about 1:4 if all the adults had antibody and only about 
1:8 if about 50 per cent of the adults were without antibody, assuming that 
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fraction. This is a very much lower level than the minimal mean titer of 1:450 
(against I00 to 1000 PDi0 of Type I virus) exhibited by the 6 patients, 3 years 
after a paralytic attack of the disease. The following questions arise as a result 
of this seeming discrepancy: (a)  Is the antibody response  of a  higher level 
after paralytic than after non-paralytic, unrecognized, or inapparent infections? 
(b) Is it possible that the level of antibody continues  to drop over the years, 
so that, in general, adults might be expected  to have lower titers than those 
encountered 3 years after infection? (c) Does the gamma globulin really carry 
all of the Type I poliomyelitis antibody, and is there no denaturation in the 
process of fractionation? At the present time there are no data on the levels 
of Type I poliomyelitis antibody in the sera of children and adults who acquired 
it as a result of inapparent or unrecognized infection, but such data are avail- 
able for Type 2 poliomyelitis antibody. Turner and his associates (9) performed 
quantitative tests on the sera of 24 Baltimore children who developed Lansing 
neutralizing antibodies,  without clinical evidence of poliomyelitis, while under 
periodic observation  of the investigators.  Using 200 LD60 of virus they found 
titers of 1:2048 in 75 per cent, 1:512 in 4 per cent, 1:128 in 8 per cent,  1:32 
in 8 per cent, and 1:8 in 4 per cent. In a study on 51 individuals from the same 
environment, aged 14 to 75 years, Bell (I0) found the following serum titers 
of antibody against 32 LDs0 of Lansing virus: 1:3 to I:$ in 16 per cent,  I:I0 
to 1:80  in 55 per cent, 1:100  to 1:800 in 25 per cent, and 1:1000 to 1:2000 
in 4 per cent. One of us (A. B. S.) in a hitherto unpublished study on 22 Cincin- 
nati women, aged 17 to 37 years, without history of recognized poliomyelitis, 
found the following serum titers against 50 LD6o of Lansing virus: 1:6 to 1:8 
in 9 per cent, I: 14 to I: 90 in 64 per cent, and I: 100 to I: 500 in 27 per cent. 
Since the amount of Lansing virus used in the titrations of the adult sera was 
only ~  or ~  of that employed by Turner and his associates  (9)  in the tests 
on the sera of the recently infected children, the difference between the levels 
of antibody found in the two groups is even more striking.  It is clear, there- 
fore,  that  inapparent  or  unrecognized  infection  with  Type  2  poliomyelitis 
virus, as a rule, gives rise to very high levels of neutralizing antibody, which 
diminish over the years but are still quite high in a considerable proportion of 
the adult population. That repeated antigenic stimuli probably play little or 
no part in maintaining this level of antibody in adults is evident from the 
work  of Paul, Riordan, and Melnick (7), who found that approximately 50 
per cent of 27 Eskimos, aged 19 to 72 years, had Lansing antibody in titers of 
I: I00  or more  against 80  LD60 of virus;  the  circumstances  suggested  that 
these  Eskimos probably had their last inapparent or unrecognized  infection 
with Type 2 poliomyelitis virus not less than 19 years ago. 
It is noteworthy that Bodian (8) found that 23 times concentrated human 
plasma gamma globulin yielded a titer of only I: 250 against I00 PDs0 of Lans- 
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performed in mice and it is quite possible  that  the  results  obtained  in  mice 
and  monkeys may not  be  comparable.  It  is well to remember, for example. 
that in the monkey tests the inoculum is 15 to 30 times greater than for mice, and 
that the 100 PD~0 dose of virus is mixed with a proportionately larger amount of 
antibody. Nevertheless, in a  subsequent  test  in mice  the  same lot of gamma 
globulin yielded a titer of 1:630 against 32 LDs0 of Lansing virus (11); in sim- 
ilar tests in mice on other lots of gamma globulin, Bodian (11) obtained titers 
of 1:320 and 1:500. However, Rhodes and Clark  (12)  tested 7 lots of human 
plasma gamma globulin  in mice against  20  LDs0  of  Lansing  virus,  and  ob- 
tained  titers which varied from  1:800  to  1:10,000,  the  mean  being  about 
1:3,000.  Since  Bodian  (11)  observed his  mice for 3 weeks  after inoculation 
while Rhodes and Clark  (12)  observed theirs for 5 weeks, there is reason  for 
assuming (4) that on a 5 week  observation basis,  Bodian's  32  LDs0  of virus 
may actually be equivalent  to  100 LDs0,  and  that  the  antibody  levels  he 
obtained might,  therefore, be expected to be  substantially  lower than  those 
of Rhodes and Clark. The experience recorded in  the present investigation of 
the rather unexpected differences in the titer of some of the sera, which were ob- 
tained in two separate tests using slightly different dilutions or different prep- 
arations  of  the  same  strain of Type 1 virus, indicates how hazardous it can 
be to compare levels of antibody which are  determined  with different types, 
strains,  and amounts of virus, in different hosts, and at different times.  It is 
evident, therefore, that further studies by standardized techniques are needed 
to answer the questions  previously  raised  regarding  the  levels  of  Type  1 
antibody  in  children  and adults,  without  history  of  poliomyelitis,  and  of 
its  distribution  among  the various protein fractions of human  plasma. 
sums~a~Y 
Quantitative  neutralization tests  in  monkeys were carried out on sera  ob- 
tained from 7 patients, 3 months, and 3 years after an attack of poliomyelitis. 
The serum specimens were tested against  100  to  1000  PDs0  of the patient's 
own strain of virus,  recovered during the  acute phase  of the  illness; all  the 
strains were Type 1. The 6 patients, aged 6 months to 13 years, who had a 
paralytic attack of the disease,  all exhibited very high levels of neutralizing 
antibody at 3 years as well as at 3 months after onset. The 50 per cent serum 
dilution titers ranged from about 1:180 to at least 1:860. Since the maximum 
titers were not established,  it is not known to what extent, if any,  the level 
of antibody may have dropped over the 3 year period. One of the patients, 
with a diagnosis of non-paralytic poliomyelitis, had a negligible or questionable 
antibody response during convalescence and no demonstrable antibody at 3 
years; there is justifiable doubt as to whether the Type 1 poliomyelitis virus 
recovered from this patient had actually caused infection. 
Tests for Lansing neutralizing antibody indicated that  the 5 patients who J'OHAN  WINSSER  AND  ALBERT  B.  SABIN"  487 
had no evidence of previous infection with Type 2 poliomyelitis virus had not 
become infected with it during the 3 year period. This suggested that these 
patients did not live in an environment in which infection with poliomyelitis 
virus is frequent. It is concluded, therefore, that in human beings, paralytic 
infections due to Type I  poliomyelitis virus produce large amounts of homo- 
typic neutralizing antibody, which persists at high levels for a  period of at 
least 3 years. 
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APPENDIX 
Protocols of Neutralization  Tests in Monkeys 
TABLE V 
Neutralizing Antibody in 3 Month  and 3 Year Sera against Patient's Own Virus 
Patient I  Final I 
and  dilu-  ! 
strain  I  testea  ttonoll 
of virus I  serum 
Obe.  Saline  -- 
3 mo. 
Poliomyelitis in monkeys at indicated final dilutions of virus 
10-2  10-8 
7,  9,  10,  14 
1:8  0,  0,  0,  0 
1:32  0,  0,  0,  0 
1:128  0,  0,  ~),  (~ 
1:512  9,  0,  0,  0 
1:2  0,  0,  0 
1:8  0,  0,  0,  0 
3 yr.  1:32  0,  0,  0,  0 
I:128NP,  0,  0,  0 
1:512  0,  0,  0,  0 
Ric.  Saline  --  6,  7,  9,  O 
1:32  0,  0,  @,  @ 
3mo.  1:128  0,  O,  O,  @ 
1:512  O,  O,  O, 
3 yr. 
S dine 
3 too. 
3 yr. 
Saline 
1:2  0,  0,  0, 
1:8  0,  0,  0,  0~) 
1:32  0,  0,  0, 
1:128  6,  0,  0,  0 
1:512  0,  @,  ®,  ® 
--  5,  6,  7,  9 
1:8  0,  0,  0,  0 
1:32  0,  0,  @,  (~) 
1:128  0,  0,  0,  0 
1:2  0,  0,  0,  0 
1:8  0,  0,  0,  0 
1:32  11,  0,  0,  0 
1:128  11,  0,  0,  0 
i 
--  6,  7,  8,  12 
1:2  O,  O,  0,  0 
1:8  O,  O,  O,  0 
1:32  0,  0,  ~),  @ 
1:128!  0,  0,  0,  0 
1:2  0,  0,  0,  0 
1:8  O,  O,  O,  0 
1:32  O,  O,  O,  (~ 
1:128  O,  O,  O,  0 
Ris. 
~d ~ / 50 per cent 
~, ~ [ protective 
T,  dilution 
of serum 
Fro. 
3 too. 
3 yr. 
7,  9,  NP,  0 
9  10-4  10-5  10-  -- 
,  13,  0,  0  7,  NP,  0,  0  4.2 
,,  7,  9,  1216,  ,,  1,,  010.  o,  o,  .],.3 
9,  9.  10.  019,  9.  9.  ,7111,  o,  o.  0  I,., 
7,  8,  9,  12  [6,  12,  O,  0110,  O,  O,  0]4.2 
1:776+? 
1:860+? 
1:1024+? 
1: 724+? 
i:  256+? 
I:  16o+? 
1: 256+? 
1: 256+? a~ 
o~ 
°~ 
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TABLE  VII 
Patient Hof.: Neutralizing Antibody in 3 Month and 3 Year Sera against Patient's Own Virus 
Serum 
tested 
Saline 
3 too. 
3 yr. 
Fh~ll 
dilu-J 
tton l 
ot se-I 
rum  l  lO-Sa 
--  ,5,  6,  9,  9 
1:2  [9,  9,  9,  20 
1:8  i7,  7,  8,  9 
1:32[5,  6,  7,  9 
1:2  17,  7,  7,  10 
1:8  16,  7,  10,  ® 
1:3217,  8,  10,  10 
Poliomyelitis in monkeys st indicated final dilutions of virus  Titer 
of 
virus 
lO-Sa  lO-~a  10-6.7 
i 
5,  6,  I1,  1  O,  O,  0,  0,  0,  0,  I1  4.2 
50 per 
cent 
pro- 
tective 
dilu- 
tion of 
seruln 
<1:2 
<1:2 